The effect of mescaline and bufotenine on some central actions of noradrenaline.
D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D003864:Depression, Chemical; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006213:Hallucinogens / Q000494:pharmacology*; D006591:Hexobarbital / Q000494:pharmacology; D006801:Humans; D007035:Hypothermia / Q000139:chemically induced; D008635:Mescaline / Q000494:pharmacology*; D051379:Mice; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D011941:Receptors, Adrenergic
D006213:Hallucinogens; D011941:Receptors, Adrenergic; D006591:Hexobarbital; D000654:Amobarbital; D008635:Mescaline; D010433:Pentylenetetrazole; D009638:Norepinephrine